Hugo Bellut

Hugo Bellut

Auto-generated profile, based on publicly available information

Hugo Bellut

Service de réanimation, Hôpital A. Mignot, CH Versailles, 177 Rue de Versailles, 78157 Le Chesnay, France

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2023 in Infectious Diseases Now
Verified
Journal Article
Closed access
HBHugo Bellut
Hugo Bellut
MAMarine Arrayago
Marine Arrayago
MAMarlène Amara
Marlène Amara
ARariane roujansky
ariane roujansky
MMMaité Micaelo
Maité Micaelo
JBJean-Pierre Bedos
Jean-Pierre Bedos

24 October 2021 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
HBHugo Bellut
Hugo Bellut
RPRaphael Porcher
Raphael Porcher
EVEmmanuelle VARON
Emmanuelle VARON
PAPierre Asfar
Pierre Asfar
YTYves Le Tulzo
Yves Le Tulzo
JBJean‑Pierre Bedos
Jean‑Pierre Bedos
Background: The presence of bacteraemia in pneumococcal pneumonia in critically ill patients does not appear to be a strong independent prognostic factor in the existing literature. However, there may be a specific pattern of factors associated with mortality for ICU patients with bacteraemic pneumococcal community-acquired pneumonia (CAP). We aimed to compare the factors associated with mortality, according to the presence of bacteraemia or not on admission, for patients hospitalised in intensive care for severe pneumococcal CAP. Methods: This was a post hoc analysis of data from the prospective, observational, multicentre STREPTOGENE study in immunocompetent Caucasian adults admitted to intensive care in France between 2008 and 2012 for pneumococcal CAP. Patients were divided into two groups based on initial blood culture (positive vs. negative) for Streptococcus pneumoniae . The primary outcome was hospital mortality, which was compared between the two groups using odds ratios according to predefined variables to search for a prognostic interaction present in bacterial patients but not non-bacteraemic patients. Potential differences in the distribution of serotypes between the two groups were assessed. The prognostic consequences of the presence or not of initial bi-antibiotic therapy were assessed, specifically in bacteraemic patients. Results: Among 614 included patients, 274 had a blood culture positive for S. pneumoniae at admission and 340 did not. The baseline difference between the groups was more frequent leukopaenia (26% vs. 14%, p = 0.0002) and less frequent pre-hospital antibiotic therapy (10% vs. 16.3%, p = 0.024) for the bacteraemic patients. Hospital mortality was not significantly different between the two groups ( p = 0.11). We did not observe any prognostic factors specific to the bacteraemic patient population, as the statistical comparison of the odds ratios, as an indication of the association between the predefined prognostic parameters and mortality, showed them to be similar for the two groups. Bacteraemic patients more often had invasive serotypes but less often serotypes associated with high case fatality rates ( p = 0.003). The antibiotic regimens were similar for the two groups. There was no difference in mortality for patients in either group given a beta-lactam alone vs. a beta-lactam combined with a macrolide or fluoroquinolone. Conclusion: Bacteraemia had no influence on the mortality of immunocompetent Caucasian adults admitted to intensive care for severe pneumococcal CAP, regardless of the profile of the associated prognostic factors.

1 August 2019 in Resuscitation
Verified
Journal Article
Closed access
HBHugo Bellut
Hugo Bellut
LGLucie Guillemet
Lucie Guillemet
WBWulfran Bougouin
Wulfran Bougouin
JCJulien Charpentier
Julien Charpentier
OSOmar Ben Hadj Salem
Omar Ben Hadj Salem
ACAlain Cariou
Alain Cariou

11 June 2021 in Research Square
Verified
Preprint
Open access
PDF file
HBHugo Bellut
Hugo Bellut
RPRaphael Porcher
Raphael Porcher
EVEmmanuelle Varon
Emmanuelle Varon
PAPierre Asfar
Pierre Asfar
YTYves LE Tulzo
Yves LE Tulzo
JBJean‑Pierre Bedos
Jean‑Pierre Bedos
Background: The presence of bacteraemia in pneumococcal pneumonia in critically ill patient does not appear to be a strong prognostic factor on its own from the existing literature, but there may be a specific pattern of factors associated with mortality in ICU patients with bacteraemic pneumococcal pneumococcal community-acquired pneumonia (CAP).We aimed to identify factors associated with mortality in patients admitted to intensive care for severe bacteraemic CAP. Methods: This is a post-hoc analysis of data from the prospective, observational, multicentre STREPTOGENE study in immunocompetent Caucasian adults admitted to intensive care in France, between 2008 and 2012, for bacteraemic pneumococcal CAP documented by culture and/or urinary antigenuria. Patients were divided into two groups based on initial blood culture positivity for Streptococcus pneumoniae. The primary outcome was hospital mortality. Serotypes of 339 S. pneumoniae strains were determined. Results: Of 614 included patients, 274 did and 340 did not have a blood culture positive for S. pneumoniae at admission. The only baseline difference between the groups was more frequent leukopenia in bacteraemic patients (26% vs. 14%, p =0.0002). Hospital mortality was not significantly different between groups ( p =0.11). The associations between the various prognostic parameters studied and mortality were similar in the two groups. Bacteraemic patients more often had invasive serotypes but less often had serotypes associated with high case-fatality rates ( p =0.003). Antibiotic regimens were similar in the two groups. In neither group was mortality different in patients given a beta-lactam alone vs. a beta-lactam combined with a macrolide or fluoroquinolone. Interpretation: In immunocompetent Caucasian adults admitted to intensive care for severe pneumococcal CAP, bacteraemia had no influence on mortality, regardless of the prognostic factor profile. A prospective randomised trial is warranted to confirm the absence of superiority of one treatment over others.